Service
We provide clinical decision support, adjuvant early stage diagnostics and mono/combi BITAP therapy within our BISS platform.
- Innovation
- Development
Head of Bioinformatics at IMMUNEO Therapeutics GmbH
Brandenburg an der Havel, Germany
Industry & Private Sector
www.immuneo-therapeutics.de/Brandenburg an der Havel, GermanyOur focus on developing highly targeted and effective immunizations aims to set a new standard of care, working towards a future where cancer and serious infections no longer have to be life-altering conditions. Behind this mission is a team driven by expertise, innovation, and a shared vision.
INDUSTRY: GE_Healthcare
BUSINESS ACTIVITY
INDUSTRY: MT_Medical_technology
Additional questions
General cooperation interests
Other cooperation interests - Please specify (Optional)
Clinical trial cooperation
Service
We provide clinical decision support, adjuvant early stage diagnostics and mono/combi BITAP therapy within our BISS platform.
Head of Bioinformatics at IMMUNEO Therapeutics GmbH
Brandenburg an der Havel, Germany
Project cooperation
Non-clinical and Phase I clinical trials collaborations on cancer Immunotherapy
We are developing AI based next-generation platform epitope design for precision medicine in cancer immunotherapy.
Head of Bioinformatics at IMMUNEO Therapeutics GmbH
Brandenburg an der Havel, Germany
Investment
Immuneo Therapeutics investment opportunity
Immuneo Therapuetic goal is to create innovative, precise, and personalized solutions designed to address the needs of patients.
Head of Bioinformatics at IMMUNEO Therapeutics GmbH
Brandenburg an der Havel, Germany